Quidel's C. difficile test gets FDA OK for Life's Dx platforms

03/19/2013 | GenomeWeb Daily News (free registration)

Quidel has received FDA clearance for its Molecular Direct C. difficile Assay to be used with the 7500 Fast Dx Applied Biosystems and QuantStudio Dx Real-Time PCR Instruments from Life Technologies. The test kit uses a three-step, extraction-free specimen preparation process and takes less than 70 minutes to generate results, the companies said.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ